BridgeMD
New treatment option for Hematologic Malignancies
Official title Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
ClinicalTrials.gov ID: NCT07186192
What this study is testing
- What it's testing
- The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patient Informed Consent and Willingness to Participate
- Documented informed consent of the participant and/or legally authorized representative Age and Language Criteria
- Age ≥ 18 years old at the time of enrollment
- Ability to read and understand English or Spanish for Questionnaires Nature of Illness and Treatment Related Criteria
- Relapsed or refractory hematologic malignancy
You likely can't join if
- 1. An employee who is under the direct/indirect supervision of the PI/ a co-investigator/ the study manager 2. A direct study team member
See the full eligibility criteria
- Patient Informed Consent and Willingness to Participate
- Documented informed consent of the participant and/or legally authorized representative Age and Language Criteria
- Age ≥ 18 years old at the time of enrollment
- Ability to read and understand English or Spanish for Questionnaires Nature of Illness and Treatment Related Criteria
- Relapsed or refractory hematologic malignancy
- Scheduled to receive outpatient standard of care (SOC) CAR-T therapy
- Has a FCG committed to living with the patient for the duration of the study Family Caregiver Informed Consent and Willingness to Participate
- Documented informed consent of the participant and/or legally authorized representative Age and Language Criteria
- Age ≥ 18 years old at the time of enrollment
- Ability to read and understand English or Spanish for Questionnaires Nature of Illness and Treatment Related Criteria
- Family member or friend identified by the patient and defined as a person who knows the patient well and is involved in the patient's medical care
- 1. An employee who is under the direct/indirect supervision of the PI/ a co-investigator/ the study manager 2. A direct study team member
The study team makes the final eligibility decision.
Where it's taking place
- Duarte, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Duarte, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.